Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated Metabolic Dysfunction‐Associated Steatohepatitis Cirrhosis for Fibrosis Regression and <scp>MASH</scp> Resolution
This network meta-analysis provides relative rank-order estimates of the histological efficacy of available pharmacological therapies for compensated MASH cirrhosis. These data may have implications for the design of future clinical trials.
Authors
- Shi Yin Wong
- Matheus Romano de Souza (ORCID: https://orcid.org/0000-0001-8339-2035)
- Lubna Al‐Sharif (ORCID: https://orcid.org/0000-0002-2129-4891)
- Vanio L J Antunes
- Rohit Loomba
- Daniel Q. Huang
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- National University of Singapore (SG)
- An-Najah National University (PS)
- University of California San Diego (US)
- National University Hospital (SG)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1111/apt.70565
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 31.52
Funders
- National University Health System
- Medical Research Council
- National Medical Research Council
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences